6505--Digoxin Tablets

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79724R0015
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is seeking to procure Digoxin tablets, a pharmaceutical drug, through Solicitation 36E79724R0015. The solicitation aims to establish a supply source for Digoxin 0.125mg and 0.25mg tablets to be distributed through the VA and DoD Pharmaceutical Prime Vendor (PPV) programs. Key requirements include providing pricing for the base year and four one-year option periods, including a 0.5% Cost Recovery Fee, and meeting standards for product labeling, packaging, and compatibility with automated dispensing units. The original proposal due date of May 2, 2024 has been extended to May 9, 2024.

This solicitation is not set-aside for any specific business type. The Government intends to purchase the contracted items exclusively through the PPV programs, except in limited circumstances. No information is provided about potential incumbents or current contractors. The estimated annual quantities and award value are not specified, but the contract will have a base year and four one-year option periods. The place of performance is not explicitly stated, but the items will be distributed nationwide through the VA and DoD PPV programs.

Notice text

2 versions

Update #2 · Latest ·

Digoxin Tablets

Update #1 ·

N/A

Files

File Type Posted
36E79724R0015 0002.docx DOCX document
36E79724R0015 0001.docx DOCX document
36E79724R0015.docx DOCX document

Notice history

Notice Type Posted
6505--Digoxin Tablets Effective 9/17/2024 - 9/16/2025 Digoxin Tablets 0. 125mg 100 and 1, 000 count bottles Digoxin Tablets 0. 25mg 100 and 1, 000 count bottles Award Award Notice
This notice Latest solicitation Solicitation
6505--Digoxin Tablets Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity